Somerset Therapeutics LLC is recalling 5,578 units of Somerset Therapeutics Haloperidol decanoate Injection 50mg/mL. This oil-based medication may contain trace amounts of water for injection, which is considered a foreign substance for this specific formulation. The recall affects 1 mL single-dose vials and 10-vial cartons distributed nationwide within the United States. Healthcare facilities should immediately stop using the affected lots to ensure patient safety.
The presence of water in an oil-based injectable drug can compromise the stability and quality of the medication. This defect may lead to reduced drug effectiveness or unexpected adverse reactions when administered to patients.
Recall Number: D-0506-2024; Rx only; Manufactured for Somerset Therapeutics, LLC.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.